187 related articles for article (PubMed ID: 31412224)
21. Radioiodine treatment in pediatric Graves' disease and thyroid carcinoma.
Yuan L; Yang J
J Pediatr Endocrinol Metab; 2011; 24(11-12):877-83. PubMed ID: 22308835
[TBL] [Abstract][Full Text] [Related]
22. PRE-ABLATION THYROGLOBULIN AND THYROGLOBULIN TO THYROID-STIMULATING HORMONE RATIO MAY BE ASSOCIATED WITH PULMONARY METASTASES IN CHILDREN WITH DIFFERENTIATED THYROID CANCER.
Livhits MJ; Pasternak JD; Xiong M; Li N; Gosnell JE; Yeh MW; Chiu HK
Endocr Pract; 2016 Nov; 22(11):1259-1266. PubMed ID: 27482611
[TBL] [Abstract][Full Text] [Related]
23. LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA AND BONE METASTASES.
Slook O; Levy S; Slutzky-Shraga I; Tsvetov G; Robenshtok E; Shimon I; Benbassat C; Hirsch D
Endocr Pract; 2019 May; 25(5):427-437. PubMed ID: 30657361
[No Abstract] [Full Text] [Related]
24. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
25. Clinical Features in Differentiated Thyroid Carcinoma Stratified By Lymph Node Status.
Shakil J; Cubb TD; Yehya A; Zand A; Xu J; Robbins RJ
Endocr Pract; 2020 Aug; 26(8):909-914. PubMed ID: 33471682
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of vascular invasion in differentiated thyroid carcinoma: a systematic review and meta-analysis.
Vuong HG; Kondo T; Duong UNP; Pham TQ; Oishi N; Mochizuki K; Nakazawa T; Hassell L; Katoh R
Eur J Endocrinol; 2017 Aug; 177(2):207-216. PubMed ID: 28566444
[TBL] [Abstract][Full Text] [Related]
27. Clinical Characteristics and Prognosis of Coexisting Thyroid Cancer in Patients with Graves' Disease: A Retrospective Multicenter Study.
Yoon JH; Jin M; Kim M; Hong AR; Kim HK; Kim BH; Kim WB; Shong YK; Jeon MJ; Kang HC
Endocrinol Metab (Seoul); 2021 Dec; 36(6):1268-1276. PubMed ID: 34823306
[TBL] [Abstract][Full Text] [Related]
28. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
[TBL] [Abstract][Full Text] [Related]
29. Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.
Qu N; Zhang L; Lu ZW; Ji QH; Yang SW; Wei WJ; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7797-808. PubMed ID: 26695148
[TBL] [Abstract][Full Text] [Related]
30. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
[TBL] [Abstract][Full Text] [Related]
31. LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER AND DISTANT METASTASES.
Hirsch D; Levy S; Tsvetov G; Gorshtein A; Slutzky-Shraga I; Akirov A; Robenshtok E; Shimon I; Benbassat CA
Endocr Pract; 2017 Oct; 23(10):1193-1200. PubMed ID: 28704099
[TBL] [Abstract][Full Text] [Related]
32. The association of preoperative thyroid-stimulating hormone level and the risk of differentiated thyroid cancer in patients with thyroid nodules: A systematic review and meta-analysis.
Su A; Zhao W; Wu W; Wei T; Ruan M; Li Z; Zhu J
Am J Surg; 2020 Sep; 220(3):634-641. PubMed ID: 31955813
[TBL] [Abstract][Full Text] [Related]
33. Cervical soft tissue recurrence of differentiated thyroid carcinoma after thyroidectomy indicates a poor prognosis.
Gao L; Jiang Y; Liang Z; Zhang L; Mao X; Yang X; Wang Y; Xu J; Liu R; Zhu S; Zhao R; Lai X; Zhang X; Zhang B
Int J Surg; 2017 Dec; 48():254-259. PubMed ID: 28919092
[TBL] [Abstract][Full Text] [Related]
34. Treatment and outcome of patients with Graves' disease and metastatic differentiated thyroid cancer.
Besic N; Vidergar-Kralj B
Radiol Oncol; 2023 Sep; 57(3):380-388. PubMed ID: 37665744
[TBL] [Abstract][Full Text] [Related]
35. DOES T STAGE AFFECT PROGNOSIS IN PATIENTS WITH STAGE IV B DIFFERENTIATED THYROID CANCER?
Li M; Trivedi N; Dai C; Mao R; Wang Y; Ning Y; Gu SZ; Huo L; Siddiqui AD
Endocr Pract; 2019 Sep; 25(9):877-886. PubMed ID: 31170365
[No Abstract] [Full Text] [Related]
36. Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question.
Elisei R; Molinaro E; Agate L; Bottici V; Masserini L; Ceccarelli C; Lippi F; Grasso L; Basolo F; Bevilacqua G; Miccoli P; Di Coscio G; Vitti P; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2010 Apr; 95(4):1516-27. PubMed ID: 20156922
[TBL] [Abstract][Full Text] [Related]
37. Thyroid nodules as a risk factor for thyroid cancer in patients with Graves' disease: A systematic review and meta-analysis of observational studies in surgically treated patients.
Papanastasiou A; Sapalidis K; Goulis DG; Michalopoulos N; Mareti E; Mantalovas S; Kesisoglou I
Clin Endocrinol (Oxf); 2019 Oct; 91(4):571-577. PubMed ID: 31369161
[TBL] [Abstract][Full Text] [Related]
38. Incidental thyroid carcinoma in surgery-treated hyperthyroid patients with Graves' disease: a systematic review and meta-analysis of cohort studies.
Jia Q; Li X; Liu Y; Li L; Kwong JS; Ren K; Jiang Y; Sun X; Tian H; Li S
Cancer Manag Res; 2018; 10():1201-1207. PubMed ID: 29872340
[TBL] [Abstract][Full Text] [Related]
39. Recent outcome of Graves' disease patients with papillary thyroid cancer.
Yano Y; Shibuya H; Kitagawa W; Nagahama M; Sugino K; Ito K; Ito K
Eur J Endocrinol; 2007 Sep; 157(3):325-9. PubMed ID: 17766715
[TBL] [Abstract][Full Text] [Related]
40. Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.
Lin X; Chen X; Jiru Y; Du J; Zhao G; Wu Z
Bull Cancer; 2016 Jun; 103(6):535-40. PubMed ID: 27236850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]